A comparative study of examination scores and quantitative sensory testing in diagnosis of diabetic polyneuropathy

International Journal of Diabetes in Developing Countries

Volumn 30, Issue 1, 2010, Pages 43-48

  Mythili, A ^a   Kumar, K Dileep ^a   Subrahmanyam, K A V ^a   Venkateswarlu, K ^a   Butchi, Raju G ^a  

^a ANDHRA MEDICAL COLLEGE   (India)

Author keywords

10 g semmes weinstein monofilament examination; Diabetic neuropathy examination score; Diabetic polyneuropathy; Nerve conduction studies; Quantitative sensory testing; Vibration perception threshold

Indexed keywords

EID: 77949592008     PISSN: 09733930     EISSN: 19983832     Source Type: Journal    
DOI: 10.4103/0973-3930.60007     Document Type: Article

References (22)

1. Dyck PJ. Severity and staging of diabetic polyneuropathy in Textbook of Diabetic Neuropathy. In: Gries FA, Cameron NE, Low PA, Ziegler D, editors. Stuttgart: Thieme; 2003. p. 170-175
2. Meter JW, Smit AJ, van Sonderen E, Groothoff JW, Eisma WH, Links TP. Symptom scoring systems to diagnose distal polyneuropathy in diabetes: The Diabetic Neuropathy Symptom Score. Diabetes Med 2002;19:962-965
3. Dyck PJ. Detection, characterization, and staging of polyneuropathy: Assessed in diabetics. Muscle Nerve 1988;11:21-32.
4. Meijer JWG, van Sonderen E, Blaauwwiekel EE, Smit AJ, Groothoff JW, Eisma WH, et al. Diabetic neuropathy examination: A hierarchical scoring system to diagnose distal polyneuropathy in diabetes. Diabetes Care 2000;23:750-753
5. Franklin GM, Shetterly SM, Cohen JA, Baxter J, Hamman RF. Risk factors for distal symmetric neuropathy in NIDDM. Diabetes Care 1994;17:1172-1177
6. Cabezas-Cerrato J. The prevalence of clinical diabetic polyneuropathy in Spain: A study in primary care and hospital clinic groups. Neuropathy Spanish study Group of the Spanish Diabetes Society (SDS). Diabetologia 1998;41:1263-1269
7. Weerasuriya N, Siribaddana S, Dissanayake A, Subasinghe Z, Wariyapola D, Fernando DJ. Long term complications of newly diagnosed Sri Lankan patients with Type 2 diabetes mellitus. QJ Med 1998;91:439-443
8. Dyck PJ, Kratz KM, Karnes JL, Litchy WJ, Klein R, Pach JM, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: The Rochester Diabetic Neuropathy Study. Neurology 1993:43:817-824
9. Kumar S, Ashe HC, Parnell LN, Fernando DJ, Tsigos C, Young RJ, et al. The prevalence of foot ulceration and its correlates in Type 2 diabetes: A population based study. Diabetes Med 1994;11:480-484
10. Young MJ. Breddy JL, Veves A, Boulton AJ. The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds: A prospective study. Diabetes Care 1994;17:557-560
11. Adler AI, Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Smith DG. Risk factors for diabetic peripheral sensory neuropathy: Results of the Seattle Prospective Diabetic Foot Study. Diabetes Care 1997;20:1162-1167
12. Meter JW, Bosma E, Lefrandt JD, Links TP, Smit AJ, Stewart RE, et al. Clinical diagnosis of diabetic polyneuropathy with the diabetic neuropathy symptom and diabetic neuropathy examination scores. Diabetes Care 2003;26:697-701.
13. Kumar S, Fernando DJ, Veves A, Knowles EA, Young MJ, Boulton AJ. Semmes-Weinstein monofilaments: A simple effective and inexpensive screening device for identifying diabetic patients at risk of foot ulceration. Diabetes Res Clin Pract 1991;13:63-68
14. Armstrong DG, Lavery LA, Vela SA, Quebedeaux TC, Fleischli JG. Choosing a practical screening instrument to identify patients at risk of diabetic foot ulceration. Arch Intern Med 1998;153:289-292
15. Miranda-Palma B, Basu S, Mizel MD, Sosenko JM, Boulton AJ. The monofilament as a gold standard for foot ulcer risk screening: A reappraisal. Diabetes 2003;52: A63.
16. Valk GD, de Sonnaville JJ, van Houtum WH, Heine RJ, van Ek JT, Bouter LM, et al. The assessment of diabetic polyneuropathy in daily clinical practice: Reproducibility and validity of Semmes-Weinstein monofilaments and clinical neurological examination. Muscle Nerve 1997;20:116-118
17. Paisley AN, Abbott CA, van Schie CH, Boulton AJ. A comparison of the Neuropen against standard quantitative sensory-threshold measures for assessing peripheral nerve function. Diabetes Med 2002;19:400-405
18. Booth J, Young MJ. differences in the performance of commercially available monofilaments. Diabetes Care 2000;23:984-988
19. Dyck PJ, Dyck PJ, Velosa JA, Larson TS, O'Brien PC; The Nerve Growth Factors Study Group. Patterns of quantitative sensation testing of hypoesthesia and hyperalgesia are predictive of diabetic polyneuropathy: A study of three cohorts. Diabetes Care 2000;23:510-517
20. Davis EA, Walsh P, Jones TW, Byrne GC. The use of biosthesiometry to detect neuropathy in children and adolescents with IDDM. Diabetes Care 1997;20:1448-1453
21. Boulton AJ, Kubrusly DB, Bowker JH, Skyler JS, Sosenko JM. Impaired vibratory perception and diabetic foot ulceration. Diabetes Med 1986;3:335-337
22. Nasseri K, Strers RL, Dekhuzen LS, Buster M, Bertelsmann FW. Reproducibility of different methods for diagnosing and monitoring diabetic neuropathy. Electromyogr Clin Neurophysiol 1998;38:295-299